48 to ensure patient safety, and our systems and procedures are monitored by national health authorities with regular inspections. Orifarm is approved for parallel import of pharmaceuticals by the responsible authorities and holds a manufacturer and distribution license, which entitles us to repack and distribute pharmaceuticals. Compliance with requirements is closely monitored by national and European institutions such as the European Medicines Agency (EMA). We exclusively collaborate with wholesalers in EU countries, of which all have a valid wholesaler license and a quality system in accordance with the most current Good Distribution Practice (GDP) guidelines. In this context, our suppliers are regularly audited by their locally responsible authorities. Also, we have our own supplier qualification system, which sets high standards in operational processes and quality. 1 & 2) Quality Control of Medical Product Once the originators’ pharmaceuticals from other European countries arrive at Orifarm premises, they are unloaded in a manner to prevent them from being exposed to sun, rain or cold at any time. On all our transport routes, the temperature is closely monitored. The medical products are counted and sorted. We take samples from each batch and review them based on a binding template which is called “product specification”. Only after passing all tests, are the medical products released for production which is then initiated by an order. 3) Repacking This is when the actual repackaging process of the pharmaceuticals begins. We do not only leave that to machines, but to our experienced and continuously trained staff. In this production step, every package is provided with a patient information leaflet and with either a label or a new folding box according to the specification and the sales countries’ requirements. 4) Quality Control of Finished Products Our Quality Control staff take packs from every batch and examine them very carefully by using the product specifications (see step 1) as a reference. After passing all tests, the finished goods are moved to highly qualified and officially approved staff (“Qualified Person”), who verifies that all our operations have been performed in accordance with GMP and GDP standards. Only then are the pharmaceuticals released for shipment to our consumers. 5) Delivery to Wholesalers & Pharmacies After we have made all the necessary quality control checks and released the product, the pharmaceuticals are then distributed to the wholesalers and pharmacies, ready for sale. Orifarm Group is the largest supplier of parallel imported pharmaceuticals in Europe, and we have a strong presence in the Nordic generic market. We have become an international company, and we currently operate in Denmark, Czech Republic, Germany, Sweden, Norway, Finland, the Netherlands, Austria, the UK, Orifarm creates access to great healthcare products by supplying wholesalers, pharmacies, hospitals, and patients with a wide range of pharmaceuticals. Whether by sourcing pharmaceuticals at lower costs, or by providing established household brands, it works to make healthcare a better deal for the people, partners, and communities it proudly serves. Here we learn more from Orifarm as it wins it title in the Healthcare and Pharmaceutical Awards 2023. In all parts of our business, we work toward securing that endconsumers have access to the pharmaceuticals and treatment they need to live a healthy and pain-free life. Simply put, we want to ensure the best possible quality of life for as many as we possibly can. Our products cover the entire patient journey from prevention and alleviation to treatment and follow-up. We provide a broad portfolio of healthcare treatments across several therapeutic areas and severity of illnesses. We provide treatment and relief for life-threatening diseases such as cancers and HIV. In addition, we also provide prescription pharmaceuticals to combat non-life-threatening diseases and increase quality of life for patients suffering from diseases such as rheumatism, sclerosis, and insomnia. With our over-the-counter business area, we also provide nonprescription treatments such as light painkillers, nasal congestion relief, relief from constipation, and light allergy treatment. We even provide end-users with vitamins, minerals, and food supplements to improve health. We provide high-quality products throughout the patient’s journey from prevention and alleviation to treatment and follow-up. Based on the free movement of goods and services, we import original pharmaceuticals, we repack and relabel medicines and resell the products on different markets at more affordable prices for the end-users and societies. This is known as parallel import. Parallel imported pharmaceuticals are as safe and efficient to use and subject to the same strict quality control as the original manufacturer of pharmaceuticals. We follow all legal requirements Best Imported Pharmaceuticals Supplier 2023 – Europe Creating access to health by affordable prices.
RkJQdWJsaXNoZXIy MTUyMDQwMA==